The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Open accessAbstract
Background: Dietary intake of fruit and vegetables is associated with lower incidence of hypertension, but the mechanisms involved have not been elucidated. Here, we evaluated the effect of a high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and the prevention of cardiovascular disease. Methods: Gut microbiome, cardiorenal structure/function, and blood pressure were examined in sham and mineralocorticoid excess–treated mice with a control diet, high-fiber diet, or acetate supplementation. We also determined the renal and cardiac transcriptome of mice treated with the different diets. Results: We found that high consumption of fiber modified the gut microbiota populations and increased the abundance of acetate-producing bacteria independently of mineralocorticoid excess. Both fiber and acetate decreased gut dysbiosis, measured by the ratio of Firmicutes to Bacteroidetes, and increased the prevalence of Bacteroides acidifaciens . Compared with mineralocorticoid-excess mice fed a control diet, both high-fiber diet and acetate supplementation significantly reduced systolic and diastolic blood pressures, cardiac fibrosis, and left ventricular hypertrophy. Acetate had similar effects and markedly reduced renal fibrosis. Transcriptome analyses showed that the protective effects of high fiber and acetate were accompanied by the downregulation of cardiac and renal Egr1 , a master cardiovascular regulator involved in cardiac hypertrophy, cardiorenal fibrosis, and inflammation. We also observed the upregulation of a network of genes involved in circadian rhythm in both tissues and downregulation of the renin-angiotensin system in the kidney and mitogen-activated protein kinase signaling in the heart. Conclusions: A diet high in fiber led to changes in the gut microbiota that played a protective role in the development of cardiovascular disease. The favorable effects of fiber may be explained by the generation and distribution of one of the main metabolites of the gut microbiota, the short-chain fatty acid acetate. Acetate effected several molecular changes associated with improved cardiovascular health and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One example includes a recent rodent hypertension study in which either a high-fiber diet (a prebiotic) or acetic acid alone (a gut microbial product) resulted in reduced blood pressure and adverse cardiac remodeling168.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [168]
In the citing paper
“A significant proportion of the SCFAs produced in the distal bowel is reabsorbed from the gut lumen by facilitated apical solute transport via multiple different transporters114–117 as well as via passive (concentration-dependent) diffusion118.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [118]
In the citing paper
“Finally, studies in animal models and in patients with hypertension have reported that interventions that target the gut microbiota, such as a high-fibre diet, probiotics and antibiotics, have blood-pressure lowering effects87,92–99.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
In the citing paper
“In DOCA-salt hypertensive mice, a high-fibre diet led to substantial reductions in both SBP and DBP (~20 mmHg)95.”
From The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease (2018) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1038/mi.2016.1042 · DOI
Cited by
Sorted by citations
Items 201–300 of 998
Sanada, T. J., Hosomi, K., Shoji, H., Park, J., Naito, A., Ikubo, Y., Yanagisawa, A., Kobayashi, T., Miwa, H., Suda, R., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020929147 · Cited by 69
Adding insult to injury - Inflammation at the heart of cardiac fibrosis
Smolgovsky, S. A., Ibeh, U., Tamayo, T. P., & Alcaide, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109828 · Cited by 71
The gut microbiome and heart failure: A better gut for a better heart
Branchereau, M., Burcelin, R., & Heymes, C. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09519-7 · Cited by 74
Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies
Guo, Y., Li, X., Wang, Z., & Yu, B. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.650227 · Cited by 68
Dietary fibre and the gut–brain axis: microbiota-dependent and independent mechanisms of action
Torre, D. L., Verbeke, K., & Dalile, B. (2021) · Gut Microbiome · doi:10.1017/gmb.2021.3 · Cited by 74
Saeedi Saravi, S. S., Pugin, B., Constancias, F., Shabanian, K., Spalinger, M., Thomas, A., Le Gludic, S., Shabanian, T., Karsai, G., Colucci, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00864-8 · Cited by 68
Liu, F., Zhang, N., Li, Z., Wang, X., Shi, H., Xue, C., Li, R. W., & Tang, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-05860-6 · Cited by 70
Role of the Gut Microbiota in Stroke Pathogenesis and Potential Therapeutic Implications
Yamashiro, K., Kurita, N., Urabe, T., & Hattori, N. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000516398 · Cited by 72
Feng, R., Wang, Q. K., Yu, T., Hu, H., Wu, G., Duan, X., Jiang, R., Xu, Y., & Huang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112341 · Cited by 67
Raizada, M. K., Joe, B., Bryan, N. S., Chang, E. B., Dewhirst, F. E., Borisy, G. G., Galis, Z. S., Henderson, W. A., José, P. A., Ketchum, C. J., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09699 · Cited by 66
Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-analysis
Chi, C., Li, C., Wu, D., Buys, N. J., Wang, W., Fan, H., & Sun, J. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-01041-5 · Cited by 65
Kapur, R., Kim, M. H., Rebetz, J., Hallström, B. M., Björkman, J., Takabe-French, A., Kim, N., Liu, J., Shanmugabhavananthan, S., Milosevic, S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018903 · Cited by 65
Polsinelli, V. B., Sinha, A., & Shah, S. J. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0370-8 · Cited by 64
Gough, E. K., Edens, T. J., Geum, H. M., Baharmand, I., Gill, S. K., Robertson, R. C., Mutasa, K., Ntozini, R., Smith, L. E., Chasekwa, B., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103421 · Cited by 65
From obesity through gut microbiota to cardiovascular diseases: a dangerous journey
Marzullo, P., Renzo, L. D., Pugliese, G., Siena, M. D., Barrea, L., Muscogiuri, G., Colao, A., & Savastano, S. (2020) · International Journal of Obesity Supplements · doi:10.1038/s41367-020-0017-1 · Cited by 64
Mahdavi‐Roshan, M., Salari, A., Kheirkhah, J., & Ghorbani, Z. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.09.006 · Cited by 63
Then, C. K., Paillas, S., Wang, X., Hampson, A., & Kiltie, A. E. (2020) · BMC Biology · doi:10.1186/s12915-020-00836-x · Cited by 63
Hsu, C., Hou, C., Chang‐Chien, G., Lin, S., & Tain, Y. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001116 · Cited by 62
Deng, F., Zhang, L.-Q., Wu, H., Chen, Y., Yu, W., Han, R., Han, Y., Zhang, X., Sun, Q., Lin, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.67724 · Cited by 62
The gut microbiota and blood pressure in experimental models
Jama, H. A., Kaye, D. M., & Marques, F. Z. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000476 · Cited by 63
Self-citationVirwani, P. D., Qian, G., Hsu, M. S. S., Pijarnvanit, T. K. K. T. S., Cheung, C. N.-M., Chow, Y. H., Lok Kan, T. A. N. G., Tse, Y.-H., Xian, J.-W., Shirley Sau-Wing, L. A. M., et al. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20752 · Cited by 66
Model microbial communities for ecosystems biology
Blasche, S., Kim, Y., Oliveira, A. P., & Patil, K. R. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.09.002 · Cited by 61
Gut microbiota in kidney disease and hypertension
Antza, C., Stabouli, S., & Kotsis, V. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.028 · Cited by 61
Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure
Iwashita, M., Nagatomo, Y., Kawai, A., Taruoka, A., Yumita, Y., Kagami, K., Yasuda, R., Toya, T., Ikegami, Y., Masaki, N., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111805 · Cited by 68
Yang, M., & Lao, L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00158 · Cited by 60
Sodium, hypertension, and the gut: does the gut microbiota go salty?
Smiljanec, K., & Lennon, S. L. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00312.2019 · Cited by 62
The emerging role of gut microbial metabolism on cardiovascular disease
Kasahara, K., & Rey, F. E. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.09.007 · Cited by 59
Valdes, D. S., So, D., Gill, P. A., & Kellow, N. J. (2021) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2020.12.002 · Cited by 64
Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases
Mutalub, Y. B., Abdulwahab, M., Mohammed, A., Yahkub, A. M., Al-Mhanna, S. B., Yusof, W., Tang, S. P., Rasool, A. H. G., & Mokhtar, S. S. (2022) · Foods · doi:10.3390/foods11172575 · Cited by 64
Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity
Bu, J., & Wang, Z. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/6458094 · Cited by 59
Sequence meets function—microbiota and cardiovascular disease
Kim, M., Huda, M. N., & Bennett, B. J. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab030 · Cited by 62
Advances in pathogenesis and treatment of essential hypertension
Ma, J., & Chen, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1003852 · Cited by 77
Update on gut microbiota in cardiovascular diseases
Qian, B., Zhang, K., Li, Y., & Sun, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1059349 · Cited by 63
Waghulde, H., Cheng, X., Galla, S., Mell, B., Cai, J., Pruett‐Miller, S. M., Vázquez, G., Patterson, A. D., Kumar, M. V., & Joe, B. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11175 · Cited by 58
Roles of short-chain fatty acids in kidney diseases
Li, L.-Z., Tao, S., Ma, L., & Fu, P. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000228 · Cited by 57
Xie, M., Tao, W., Wu, F., Wu, K., Huang, X., Ling, G., Zhao, C., Lv, Q., Wang, Q., Zhou, X., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.008 · Cited by 56
Maiuolo, J., Carresi, C., Gliozzi, M., Mollace, R., Scarano, F., Scicchitano, M., Macrì, R., Nucera, S., Bosco, F., Oppedisano, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073698 · Cited by 57
Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage
Avery, E. G., Bartolomaeus, H., Rauch, A., Chen, C., N’Diaye, G., Löber, U., Bartolomaeus, T. U. P., Fritsche‐Guenther, R., Rodrigues, A. F., Yarritu, A., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac121 · Cited by 59
BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21
Zheng, H. X., Zhang, X., Li, C., Wang, D., Shen, Y., Lu, J., Zhao, L., Li, X., & Gao, H. (2024) · Microbiome · doi:10.1186/s40168-024-01872-3 · Cited by 59
The impact of gut microbiota metabolites on cellular bioenergetics and cardiometabolic health
Tomášová, L., Grman, M., Ondriaš, K., & Ufnal, M. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00598-5 · Cited by 58
Yang, T., Mei, X., Tackie‐Yarboi, E., Akere, M. T., Kyoung, J., Mell, B., Yeo, J., Cheng, X., Zubcevic, J. A., Richards, E. M., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.121.18711 · Cited by 58
Jiang, T., Xing, X., Zhang, L., Liu, Z., Zhao, J., & Liu, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7658052 · Cited by 56
Li, Q., Larouche‐Lebel, É., Loughran, K. A., Huh, T. P., Suchodolski, J. S., & Oyama, M. A. (2021) · mSystems · doi:10.1128/msystems.00111-21 · Cited by 64
Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases
Xu, J., & Yang, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1936379 · Cited by 61
A plant-based diet and hypertension.
Alexander, S., Ostfeld, R. J., Allen, K., & Williams, K. A., Sr. (2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.05.014 · Cited by 57
Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System
Robles‐Vera, I., Toral, M., & Duarte, J. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa103 · Cited by 57
Association Between Dietary Inflammatory Index and Heart Failure: Results From NHANES (1999–2018)
Liu, Z., Liu, H., Deng, Q., Sun, C., He, W., Zheng, W., Tang, R., Li, W., & Xie, Q. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.702489 · Cited by 54
Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
Huang, Z., Mei, X., Jiang, Y., Chen, T., & Zhou, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.803744 · Cited by 54
Lu, C., Ma, K. L., Ruan, X. Z., & Liu, B. C. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.25543 · Cited by 54
Association between hypertension, oral microbiome and salivary nitric oxide: A case-control study
Barbadoro, P., Ponzio, E., Coccia, E., Prospero, E., Santarelli, A., Rappelli, G., & D’Errico, M. M. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.11.002 · Cited by 57
Different gender-derived gut microbiota influence stroke outcomes by mitigating inflammation
Wang, J., Zhong, Y., Zhu, H., Mahgoub, O. K., Jian, Z., Gu, L., & Xiong, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02606-8 · Cited by 53
Martemucci, G., Khalil, M., Luca, A. D., Abdallah, H., & D‘Alessandro, A. G. (2024) · Metabolites · doi:10.3390/metabo14060327 · Cited by 60
Interactions between Gut Microbiota, Host Circadian Rhythms, and Metabolic Diseases
Zhang, M., Zhou, C., Li, X., Li, H., Han, Q., Chen, Z., Tang, W., & Yin, J. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100416 · Cited by 58
Microbiome and hypertension: where are we now?
Vallianou, N. G., Geladari, E. V., & Kounatidis, D. C. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000900 · Cited by 55
Hsu, C., Hou, C., Hsu, W.-H., & Tain, Y. (2021) · Nutrients · doi:10.3390/nu13072290 · Cited by 52
Targeting Gut Microbiota to Treat Hypertension: A Systematic Review
Palmu, J., Lahti, L., & Niiranen, T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031248 · Cited by 55
Gut Microbiome and Organ Fibrosis
Costa, C. F. F. A., Sampaio‐Maia, B., Araújo, R., Nascimento, D. S., Ferreira‐Gomes, J., Pestana, M., Azevedo, M. J., & Alencastre, I. S. (2022) · Nutrients · doi:10.3390/nu14020352 · Cited by 53
Double-side role of short chain fatty acids on host health via the gut-organ axes
Gao, Y., Yao, Q., Meng, L., Wang, J., & Zheng, N. (2024) · Animal nutrition · doi:10.1016/j.aninu.2024.05.001 · Cited by 58
Modulation of the Gut Microbiota by Krill Oil in Mice Fed a High-Sugar High-Fat Diet
Lu, C., Sun, T., Li, Y., Zhang, D., Zhou, J., & Su, X. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00905 · Cited by 51
Hsu, C., Yang, H., Hou, C., Chang‐Chien, G., Lin, S., & Tain, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197237 · Cited by 51
Canale, M. P., Noce, A., Lauro, M. D., Marrone, G., Cantelmo, M., Cardillo, C., Federici, M., Daniele, N. D., & Tesauro, M. (2021) · Nutrients · doi:10.3390/nu13041162 · Cited by 51
Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axis
Sun, P., Zhang, C., Huang, Y., Yang, J., Zhou, F., Zeng, J., & Lin, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112975 · Cited by 53
Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure
Zhao, P., Zhao, S., Tian, J., & Liu, X. (2022) · Nutrients · doi:10.3390/nu14183758 · Cited by 53
Gut microbiota dependant trimethylamine N-oxide and hypertension
Mutengo, K. H., Masenga, S. K., Mweemba, A., Mutale, W., & Kirabo, A. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1075641 · Cited by 53
Moleón, J., González‐Correa, C., Miñano, S., Robles‐Vera, I., de la Visitación, N., Barranco, A. M., Gómez‐Guzmán, M., Sánchez, M., Riesco, P., Guerra-Hernández, E. J., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106997 · Cited by 53
Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control
Jama, H. A., Snelson, M., Schutte, A. E., Muir, J. G., & Marques, F. Z. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22575 · Cited by 55
Self-citationTakei, M., Kuda, T., Taniguchi, M., Nakamura, S., Hajime, T., & Kimura, B. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116205 · Cited by 50
Zhang, Q., Ran, X., He, Y., Ai, Q., & Shi, Y. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.595157 · Cited by 50
Li, B., He, X., Jin, H., Wang, H.-Y., Zhou, F.-C., Zhang, N., Dong-ying, J., Li, L.-Z., Su, J., Zheng, X., et al. (2021) · Food & Function · doi:10.1039/d0fo02890h · Cited by 50
Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
Tan, J., Taitz, J., Nanan, R. K. H., Grau, G. E., & Macia, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015256 · Cited by 58
Self-citationDiet-related gut microbial metabolites and sensing in hypertension
Muralitharan, R. R., & Marques, F. Z. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-0388-3 · Cited by 51
Self-citationAbais‐Battad, J. M., Saravia, F. L., Lund, H., Dasinger, J. H., Fehrenbach, D. J., Alsheikh, A. J., Zemaj, J., Kirby, J. R., & Mattson, D. L. (2021) · Acta Physiologica · doi:10.1111/apha.13662 · Cited by 49
Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
McCarthy, C. G., Saha, P., Golonka, R. M., Wenceslau, C. F., Joe, B., & Vijay–Kumar, M. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200020 · Cited by 48
Role of the microbiota in hypertension and antihypertensive drug metabolism
Mishima, E., & Abe, T. (2021) · Hypertension Research · doi:10.1038/s41440-021-00804-0 · Cited by 50
Association Between the Gut Microbiome and Their Metabolites With Human Blood Pressure Variability
Dinakis, E., Nakai, M. E., Gill, P. A., Ribeiro, R. V., Yiallourou, S. R., Sata, Y., Muir, J. G., Carrington, M. J., Head, G. A., Kaye, D. M., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19350 · Cited by 50
Self-citationRegulatory effect of gut microbes on blood pressure
Yan, D., Sun, Y. Q., Zhou, X., Si, W., Liu, J., Li, M., & Wu, M. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12233 · Cited by 50
Azuma, N., Mawatari, T., Saito, Y., Tsukamoto, M., Sampei, M., & Iwama, Y. (2023) · Nutrients · doi:10.3390/nu15194175 · Cited by 54
Pi, Y., Fang, M., Li, Y., Cai, L., Han, R., Sun, W., Jiang, X., Chen, L., Du, J., Zhu, Z., et al. (2024) · Nutrients · doi:10.3390/nu16172838 · Cited by 55
Gao, Y., Yang, L., Chin, Y., Liu, F., Li, R. W., Yuan, S., Xue, C., Xu, J., & Tang, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062149 · Cited by 49
The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development
Li, J., Yang, X., Zhou, X., & Cai, J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8104 · Cited by 51
Exploring the Gut Microbiota and Cardiovascular Disease
Murphy, K., O’Donovan, A. N., Caplice, N. M., Ross, R. P., & Stanton, C. (2021) · Metabolites · doi:10.3390/metabo11080493 · Cited by 48
The Gut–Heart Axis: Molecular Perspectives and Implications for Myocardial Infarction
Rivera, K., González, L., Bravo, L., Manjarres, L., & Andía, M. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212465 · Cited by 51
Li, D. Y., & Tang, W. H. W. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.008 · Cited by 48
Sato, F. T., Yap, Y. A., Crisma, A. R., Portovedo, M., Murata, G. M., Hirabara, S. M., Ribeiro, W. R., Ferreira, C. M., Cruz, M. M., Pereira, J. N. B., et al. (2020) · Cells · doi:10.3390/cells9092007 · Cited by 48
Kong, C., Li, Z., Mao, Y., Chen, H., Hu, W., Han, B., & Wang, L. (2021) · Food & Function · doi:10.1039/d1fo01836a · Cited by 47
Lv, Q., Li, Z., Sui, A., Yang, X., Han, Y., & Yao, R. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.977187 · Cited by 48
Wang, X., Chen, W., Jin, R., Xu, X., Wei, J., Huang, H., Tang, Y., Zou, C., & Chen, T. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14196 · Cited by 51
Gut Microbiome-Based Management of Patients With Heart Failure
Mamic, P., Snyder, M. P., & Tang, W. H. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.045 · Cited by 51
Gut microbiota determines the fate of dietary fiber-targeted interventions in host health
Wang, W., Fan, Z., Yan, Q., Pan, T., Luo, J., Wei, Y., Li, B., Fang, Z., & Lu, W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2416915 · Cited by 47
The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea
Badran, M., Mashaqi, S., & Gozal, D. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1841749 · Cited by 45
Juan, Y., Chen, Y., & Xu, M. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109013 · Cited by 47
Update on the gut microbiome in health and diseases
Salvadori, M., & Rosso, G. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.89196 · Cited by 52
Fan, L., Chen, J., Zhang, Q., Ren, J., Chen, Y., Yang, J., Wang, L., Guo, Z., Bu, P., Zhu, B., et al. (2025) · Microbiome · doi:10.1186/s40168-025-02118-6 · Cited by 52
Gut microbiota: a new angle for traditional herbal medicine research
Lin, L., Luo, L., Zhong, M., Xie, T.-G., Liu, Y., Li, H., & Ni, J. (2019) · RSC Advances · doi:10.1039/c9ra01838g · Cited by 45
Shen, S., Kumar, K. P., Wen, S., Shim, R., Wanrooy, B. J., Stanley, D., Moore, R. J., Van, T. T. H., Robert, R., Hickey, M. J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.619366 · Cited by 49
Maternal microbiome in preeclampsia pathophysiology and implications on offspring health
Ishimwe, J. A. (2021) · Physiological Reports · doi:10.14814/phy2.14875 · Cited by 45
Vijay, A., Astbury, S., Louca, P., Marques, F. Z., Spector, T. D., Menni, C., & Valdes, A. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.691564 · Cited by 45
Self-citationKemp, J. A., Paiva, B. R., dos Santos, H. F., de Jesus, H. E., Craven, H., Ijaz, U. Z., Borges, N. A., Shiels, P. G., & Mafra, D. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100374 · Cited by 45
Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract
Biruete, A., Gallant, K. M. H., Lindemann, S. R., Wiese, G. N., Chen, N. X., & Moe, S. M. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.01.004 · Cited by 48
The Role of Microbiota in Cardiovascular Risk: Focus on Trimethylamine Oxide
Al-Rubaye, H., Perfetti, G., & Kaski, J.-C. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.06.005 · Cited by 43
Metadata
- Authors
- Marques, F. Z., Nelson, E., Chu, P.-Y., Horlock, D., Fiedler, A., Ziemann, M., Tan, J. K., Kuruppu, S., Rajapakse, N. W., El-Osta, A., Mackay, C. R., & Kaye, D. M.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From Heart Failure Research Group (F.Z.M., E.N., P.-Y.C., D.H., A.F., N.W.R., D.M.K.) and Human Epigenetics Group (M.Z., A.E.-O.), Baker Heart and Diabetes Institute, Melbourne, Australia; Central Clinical School, Faculty of Medicine Nursing and Health Sciences (F.Z.M., A.E.-O., D.M.K.), Infection and Immunity Program, Monash Biomedicine Discovery Institute (J.K.T., C.R.M.), Department of Biochemistry and Molecular Biology (J.K.T., S.K., C.R.M.), and Department of Physiology (N.W.R.), Monash...
- ORCID
- Venue
- Circulation
- Published
- 2017-03-07
- Volume
- 135
- Issue
- 10
- Pages
- 964-977
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2560340862
- Cited by
- 1,065
- References
- 47
- Citations by year
- 2026: 95 · 2025: 142 · 2024: 137 · 2023: 136 · 2022: 148 · 2021: 144 · 2020: 101 · 2019: 77 · 2018: 56 · 2017: 29
- FWCI
- 28.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- State Government of Victoria
- Baker Heart and Diabetes Institute
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- high-fiber diet, acetate supplementation, gut microbiota, hypertension, heart failure, mineralocorticoid excess, Bacteroides acidifaciens, Firmicutes/Bacteroidetes ratio, myocardial fibrosis, left ventricular hypertrophy, renal fibrosis, EGR1, circadian rhythm, renin-angiotensin system, MAPK signaling, short-chain fatty acids, cardiovascular disease prevention
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Blood Pressure, Dietary Fiber, Disease Models, Animal, Fibrosis, Hypertension, Kidney, Male, Mice, Inbred C57BL, Myocardium, Organ Size, RNA, Ribosomal, 16S, Dietary Supplements, Principal Component Analysis, Gastrointestinal Tract, Mice, Transcriptome, Desoxycorticosterone Acetate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
